Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tuberculosis
Biotech
Spero halts development on another antibiotic
Having stripped back its workforce, antibiotics biotech Spero Therapeutics continues to strip away its remaining pipeline.
James Waldron
Mar 28, 2025 7:05am
Compounds from bog fungi kill tuberculosis bacteria in the lab
Dec 3, 2024 2:00pm
FDA, Gates Foundation team up on breath-based diagnostic tests
Jun 27, 2024 10:30am
Novo Nordisk Foundation sets up $260M vaccine initiative
Dec 18, 2023 11:14am
Siemens Healthineers, Qure partner on X-ray AI for TB screening
Oct 16, 2023 2:59pm
2 foundations pour $550M into phase 3 for ex-GSK TB shot
Jun 29, 2023 11:18am
